Lin Manping J Wu

US Patent:

6933759, Aug 23, 2005

Filed:

Feb 5, 2004

Appl. No.:

10/773554

Inventors:

Lin Wu - Richardson TX, US
Robert Floyd Payne - Allen TX, US
Paul Eric Landman - Allen TX, US
Woo Jin Kim - Dallas TX, US

Assignee:

Texas Instruments Incorporated - Dallas TX

International Classification:

H03K003/017

US Classification:

327172, 327175, 327100

Abstract:

The present invention facilitates serial communication by performing duty cycle correction. A duty cycle correction component performs duty cycle corrections on a pair of differential sinusoidal signals according to a pair of adjustment signals and, as a result, generates a differential pair of square wave signals. A cross coupled buffer buffers the differential pair of square wave signals and provides the buffered signals to a feedback circuit that measures duty cycles of the signals and generates the pair of adjustment signals accordingly. The buffer can also remove skew from the signals. In a transmitter , the buffered signals are also generally provided to a multiplexer or encoder and in a receiver , the buffered signals are also generally provided to a sampling component.

US Patent:

7027734, Apr 11, 2006

Filed:

Apr 25, 2002

Appl. No.:

10/132009

Inventors:

Lin Wu - San Jose CA, US
Zhupei Shi - San Jose CA, US
Yuqiao Liu - Sunnyvale CA, US
Wei-Shin Tsay - Saratoga CA, US

Assignee:

Alliance Fiber Optic Products, Inc. - Sunnyvale CA

International Classification:

H04J 14/02

US Classification:

398 79, 385140, 398158, 398 9, 398140

Abstract:

Optical devices and methods for regulating optical channel signals with specified wavelengths are disclosed. According to one aspect of the present invention, a number of variable optical apparatuses are employed. Each of the variable optical apparatuses includes a first and a second optical channel module, both configured at a wavelength λ. Each of the variable optical apparatuses further includes an optical regulator (i. e. a neutral density filter controlled by a stepper motor) coupled between the first and second optical channel modules. When signals with different wavelengths arrive, only the signal with the wavelength λwill transmit through the first optical channel module and the rest are reflected off. The transmitted signal is regulated (i. e. attenuated or strengthened) accordingly by the optical regulator before transmitting through the second optical channel module.

US Patent:

7142538, Nov 28, 2006

Filed:

Dec 22, 2001

Appl. No.:

10/027926

Inventors:

Ashok Kumar Singh - Irvine CA, US
Lin Wu - Sunnyvale CA, US
Dapeng Xiong - Irvine CA, US
Celine Yonghong Wang - Irvine CA, US

Assignee:

ADC DSL Systems, Inc. - Eden Praire MN

International Classification:

H04L 12/28
H04L 12/56

US Classification:

370392, 3703951

Abstract:

A method for communicating between cards in an electronic module is provided. The method includes generating a message for transmission at a first card. The message is transmitted over a bus to a second card by-passing an IP stack at the first card. A queue at the second card is monitored for messages from the first card. A message is read from the queue at the second card when received from the first card.

US Patent:

20080153840, Jun 26, 2008

Filed:

Dec 20, 2007

Appl. No.:

11/961860

Inventors:

Luiz Belardinelli - Palo Alto CA, US
Lin Wu - Sunnyvale CA, US
Sridharan Rajamani - Fremont CA, US
Arvinder Dhalla - Mountain View CA, US

International Classification:

A61K 31/496
A61P 9/00

US Classification:

51425212

Abstract:

The present application discloses methods for treating patients with a dysfunction of the ion channels of the heart suffering from one or more cardiovascular diseases to reduce the proarrhythmic effect of drugs and/or conditions that reduce or inhibit I.

US Patent:

20100173294, Jul 8, 2010

Filed:

Jul 30, 2009

Appl. No.:

12/512914

Inventors:

Rachel Langland - Oakland CA, US
Lin Wu - Moraga CA, US
Thad Sharp - Parsippany NJ, US
Stephen Will - Rotkreuz, CH

Assignee:

ROCHE MOLECULAR SYSTEMS, INC. - Pleasanton CA

International Classification:

C12Q 1/68

US Classification:

435 6

Abstract:

The present invention provides methods and reagents for the detection of a mutation in BRAF and methods of selecting patients for treatment if a B-Raf kinase inhibitor, such as a selective B-Raf kinase inhibitor

US Patent:

20110212991, Sep 1, 2011

Filed:

Jan 27, 2011

Appl. No.:

13/015374

Inventors:

Rachel Langland - Oakland CA, US
Lin Wu - Moraga CA, US
Thad Sharp - Parsippany NJ, US
Stephen Will - Cham, CH

Assignee:

ROCHE MOLECULAR SYSTEMS, INC. - Pleasanton CA

International Classification:

A61K 31/437
C12Q 1/68
C07H 21/04
A61P 35/00

US Classification:

514300, 435 611, 536 2431

Abstract:

The present invention provides methods and reagents for the detection of a mutation in BRAF and methods of selecting, patients for treatment if a B-Raf kinase inhibitor, such as a selective B-Raf kinase inhibitor.

US Patent:

58540032, Dec 29, 1998

Filed:

Feb 26, 1998

Appl. No.:

/032475

Inventors:

Mike Rothe - San Mateo CA
Lin Wu - South San Francisco CA

Assignee:

Tularik Inc. - South San Francisco CA

International Classification:

G01N 33566

US Classification:

435 78

Abstract:

The invention provides methods and compositions relating to a novel kinase, NIK, involved in NF. kappa. B activation. The polypeptides may be produced recombinantly from transformed host cells from the disclosed NIK encoding nucleic acids or purified from human cells. The invention provides isolated NIK hybridization probes and primers capable of specifically hybridizing with the disclosed NIK genes, NIK-specific binding agents such as specific antibodies, and methods of making and using the subject compositions in diagnosis, therapy and in the biopharmaceutical industry.

US Patent:

58440739, Dec 1, 1998

Filed:

Feb 13, 1998

Appl. No.:

/023321

Inventors:

Mike Rothe - San Mateo CA
Lin Wu - South San Francisco CA

Assignee:

Tularik Inc. - South San Francisco CA

International Classification:

C07K 412
C07K 706
C07K 708
C07K 1447

US Classification:

530300

Abstract:

The invention provides methods and compositions relating to a novel kinase, NIK, involved in NF. kappa. B activation. The polypeptides may be produced recombinantly from transformed host cells from the disclosed NIK encoding nucleic acids or purified from human cells. The invention provides isolated NIK hybridization probes and primers capable of specifically hybridizing with the disclosed NIK genes, NIK-specific binding agents such as specific antibodies, and methods of making and using the subject compositions in diagnosis, therapy and in the biopharmaceutical industry.